美国促进生物医药产业创新发展政策经验及启示

美国是全球公认的生物医药创新强国,产业规模及创新能力均处于全球领先位置.在分析美国生物医药产业创新发展现状特点的基础上,基于政府支持、研发创新平台、企业创新发展、临床审批机制以及创新生态环境等维度,深入探讨美国促进生物医药产业创新发展政策经验,并提出启示建议.

Policy Experience and Enlightenment of Promoting Innovation and Development of Biomedical Industry in the United States

The United States is recognized as a global biomedical innovation power, and its industrial scale and innovation ability are in the leading position in the world. Based on the analysis of the current situation and characteristics of the innovation and development of the biomedical industry in the United States, discusses the policy experience of promoting the innovation and development of the biomedical industry from the perspectives of government support, innovation platform, enterprise innovation and development, clinical approval mechanism and innovation ecological environment, and puts forward some enlightenment suggestions.